Correlation Between SciVision Biotech and Icares Medicus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SciVision Biotech and Icares Medicus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SciVision Biotech and Icares Medicus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SciVision Biotech and Icares Medicus, you can compare the effects of market volatilities on SciVision Biotech and Icares Medicus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SciVision Biotech with a short position of Icares Medicus. Check out your portfolio center. Please also check ongoing floating volatility patterns of SciVision Biotech and Icares Medicus.

Diversification Opportunities for SciVision Biotech and Icares Medicus

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between SciVision and Icares is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding SciVision Biotech and Icares Medicus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icares Medicus and SciVision Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SciVision Biotech are associated (or correlated) with Icares Medicus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icares Medicus has no effect on the direction of SciVision Biotech i.e., SciVision Biotech and Icares Medicus go up and down completely randomly.

Pair Corralation between SciVision Biotech and Icares Medicus

Assuming the 90 days trading horizon SciVision Biotech is expected to generate 1.09 times more return on investment than Icares Medicus. However, SciVision Biotech is 1.09 times more volatile than Icares Medicus. It trades about -0.22 of its potential returns per unit of risk. Icares Medicus is currently generating about -0.24 per unit of risk. If you would invest  10,400  in SciVision Biotech on August 26, 2024 and sell it today you would lose (1,060) from holding SciVision Biotech or give up 10.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

SciVision Biotech  vs.  Icares Medicus

 Performance 
       Timeline  
SciVision Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SciVision Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Icares Medicus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Icares Medicus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Icares Medicus is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

SciVision Biotech and Icares Medicus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SciVision Biotech and Icares Medicus

The main advantage of trading using opposite SciVision Biotech and Icares Medicus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SciVision Biotech position performs unexpectedly, Icares Medicus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icares Medicus will offset losses from the drop in Icares Medicus' long position.
The idea behind SciVision Biotech and Icares Medicus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum